A guide to biopharma solutions from Oxford Nanopore
)
Overview
Developing a new drug is a lengthy, high-risk endeavour. At every stage, decision-making depends on molecular data, whether to validate a construct, confirm integration into a production cell line, or demonstrate the integrity of a viral vector or RNA therapeutic. Yet the analytical methods traditionally used to provide that data are fragmented and incomplete.
This guide introduces Oxford Nanopore sequencing solutions that can be applied from biomarker discovery through to final product quality control (QC) testing, consolidating multiple legacy assays with one platform and enabling faster, more confident decision-making.
In this getting started guide, you will:
- Find out how Oxford Nanopore sequencing delivers the multiomic insight that other methods miss
- Discover end-to-end workflows tailored for biopharma applications, such as amplicon analysis, plasmid construct verification, viral vector characterisation, and mRNA therapeutic quality control
- Learn about the range of Oxford Nanopore devices
- Read real-world case studies of how nanopore sequencing is being used to address needs in the drug development pipeline
